Refining First-Line and Maintenance Strategies in BRAF V600-Mutated Metastatic CRC
Автор: OncUpdates: Latest Oncology Insights
Загружено: 2026-01-21
Просмотров: 1030
Описание:
Join us in this insightful episode as Daniel Tuerff, a second-year fellow at the University of Miami, sits down with Dr. Nick Hornstein, a GI medical oncologist at Norfolk Health. They dive deep into the Breakwater trial, focusing on its implications for metastatic colorectal cancer with BRAF V600E mutations.
In this episode, you'll learn about:
• The key findings from the Breakwater trial and how they are shaping current treatment strategies.
• The role of different treatment arms, including EC alone and Fulfox with EncoCitux, in clinical practice.
• Potential updates on second-line treatments and the incorporation of Fulfuri.
• The importance of maintenance therapy and managing peripheral neuropathy in patients.
• Exciting updates and future directions in colorectal cancer research.
Tune in to gain valuable insights into the evolving landscape of colorectal cancer treatment and what to expect from upcoming presentations at ASCO GI.
Website: https://oncupdates.com/
Mail: [email protected]
X/twitter: https://x.com/OncUpdates
Don't forget to like, subscribe, and hit the notification bell for more updates!
#ColorectalCancer, #BRAFmutation, #BREAKWATERtrial, #FOLFOX, #ASCOGI
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
